{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:41:05Z","timestamp":1741153265537,"version":"3.38.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"DOI":"10.7759\/cureus.80029","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:37:33Z","timestamp":1741106253000},"source":"Crossref","is-referenced-by-count":0,"title":["Intersecting Pathologies: Polycythemia Vera and Recurrent Infections in an Elderly Patient"],"prefix":"10.7759","author":[{"given":"Prince","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupam","family":"Nadella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil M","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh","family":"Edara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Polycythemia vera","author":"Lu X","year":"2025","unstructured":"Lu X, Chang R. Polycythemia vera. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","article-title":"Leukocytosis","author":"Mank V","year":"2025","unstructured":"Mank V, Azhar W, Brown K. Leukocytosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref3","unstructured":"Mayo Clinic. Thrombocytosis. (2024). Accessed. March 26, 2024: https:\/\/www.mayoclinic.org\/diseases-conditions\/thrombocytosis\/symptoms-causes\/syc-20378315."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00508-w","article-title":"Key role of inflammation in myeloproliferative neoplasms: instigator of disease initiation, progression and symptoms","volume":"14","author":"Luque LF","year":"2019","unstructured":"Luque LF, Blackmon AL, Ramanathan G, Fleischman AG. Key role of inflammation in myeloproliferative neoplasms: instigator of disease initiation, progression and symptoms. Curr Hematol Malig Rep. 2019, 14:145-53. 10.1007\/s11899-019-00508-w","journal-title":"Curr Hematol Malig Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13292","article-title":"B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-\u03b12, or combination treatment","volume":"103","author":"S\u00f8rensen AL","year":"2019","unstructured":"S\u00f8rensen AL, Bj\u00f8rn ME, Riley CH, et al.. B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-\u03b12, or combination treatment. Eur J Haematol. 2019, 103:351-61. 10.1111\/ejh.13292","journal-title":"Eur J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1345402","article-title":"Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis","volume":"6","author":"Romano M","year":"2017","unstructured":"Romano M, Sollazzo D, Trabanelli S, et al.. Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis. Oncoimmunology. 2017, 6:e1345402. 10.1080\/2162402X.2017.1345402","journal-title":"Oncoimmunology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0028","article-title":"Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study","volume":"168","author":"Hultcrantz M","year":"2018","unstructured":"Hultcrantz M, Bj\u00f6rkholm M, Dickman PW, Landgren O, Derolf \u00c5R, Kristinsson SY, Andersson TM. Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study. Ann Intern Med. 2018, 168:317-25. 10.7326\/M17-0028","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.020412","article-title":"Autoimmunity and the risk of myeloproliferative neoplasms","volume":"95","author":"Kristinsson SY","year":"2010","unstructured":"Kristinsson SY, Landgren O, Samuelsson J, Bj\u00f6rkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica. 2010, 95:1216-20. 10.3324\/haematol.2009.020412","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0027-y","article-title":"Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients","volume":"32","author":"Landtblom AR","year":"2018","unstructured":"Landtblom AR, Bower H, Andersson TM, et al.. Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia. 2018, 32:2203-10. 10.1038\/s41375-018-0027-y","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.019","article-title":"How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015","volume":"36","author":"Jorgensen P","year":"2018","unstructured":"Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015. Vaccine. 2018, 36:442-52. 10.1016\/j.vaccine.2017.12.019","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0909-7","article-title":"Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients","volume":"35","author":"Landtblom AR","year":"2021","unstructured":"Landtblom AR, Andersson TM, Dickman PW, et al.. Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients. Leukemia. 2021, 35:476-84. 10.1038\/s41375-020-0909-7","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/332870-intersecting-pathologies-polycythemia-vera-and-recurrent-infections-in-an-elderly-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:37:35Z","timestamp":1741106255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/332870-intersecting-pathologies-polycythemia-vera-and-recurrent-infections-in-an-elderly-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.80029","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}